25年來(lái)在中國(guó)和美國(guó)藥品和醫(yī)療器械領(lǐng)域，從產(chǎn)品研發(fā)到上市的生命周期管理方面的經(jīng)驗(yàn)。她熟悉國(guó)內(nèi)創(chuàng)新藥公司和跨國(guó)企業(yè)的運(yùn)作 。她曾任昆泰大中華區(qū)首席醫(yī)學(xué)管。成功主導(dǎo)過(guò)多項(xiàng)新藥臨床開(kāi)發(fā)項(xiàng)目。在醫(yī)學(xué)、臨床運(yùn)營(yíng)、方案設(shè)計(jì)等方面擁有豐富經(jīng)驗(yàn)。她曾在法國(guó)皮爾法伯制藥、Parexel等外資制藥企業(yè)和CRO擔(dān)任亞太臨床和醫(yī)學(xué)負(fù)責(zé)人。也曾擔(dān)任中國(guó)臨床腫瘤學(xué)會(huì) (CSCO) 臨床研究和藥物安全委員會(huì)委員.
參加編審多本醫(yī)學(xué)書(shū)籍、撰寫(xiě)并發(fā)表SCI文章，曾任CMAO（中華醫(yī)學(xué)事務(wù)）醫(yī)學(xué)聯(lián)絡(luò)官專(zhuān)委會(huì)主席 張醫(yī)生畢業(yè)于上海交通大學(xué)醫(yī)學(xué)院并在英國(guó)卡的夫商學(xué)院獲得工商管理學(xué)碩士（MBA）。她曾在臨床呼吸內(nèi)科工作。在美國(guó)印第安納州大學(xué)醫(yī)學(xué)中心工作了4年,于2006年回國(guó)后一直從事臨床研發(fā)和醫(yī)學(xué)事務(wù)工作。 ? Helena, MD, MBA is the Chief Medical Officer (CMO) of Convalife. Dr. Zhang joined the biopharmaceutical industry in 1996 and had gained a wealth of experience on product life-cycle management both in the field of drug and medical device in China and US. She was the Chief Medical Officer for Quintiles, now IQVIA in the Greater China region. She is familiar with the operation of domestic innovative drug companies and multinational companies. She has successfully led a number of new drug clinical development projects. Her rich experiences cover medical, clinical operation and study design etc. She served as the head of clinical and medical of Asia Pacific region in MNC pharmaceutical company and CRO such as Pierre Fabre medicament and Parexel. She also served as the key board member of the clinical research and drug safety committee of the Chinese Society of Clinical Oncology (CSCO). She wrote and published SCI papers, and served as the Chairman of Medical Science Liaison Committee, CMAO (Chinese Medical Affairs Organization) Dr. Zhang graduated from the medical school of Shanghai Jiaotong University and obtained a master of Business Administration (MBA) from Cardiff Business School in the UK. She practiced clinical medicine in the hospital. She worked in the medical center of Indiana University, US for four years and has been engaged in clinical development and medical affairs since returning home in 2006. |